Form 4: Director Jacob Frenkel Receives 200,000 BCLI Shares

BrainStorm Cell Therapeutics director Jacob A. Frenkel was granted 200,000 restricted stock units as part of the company's 2014 Global Share Option Plan.

Summary

• Director Jacob A. Frenkel acquired 200,000 shares of BrainStorm Cell Therapeutics (BCLI) common stock via restricted stock units (RSUs).
• The transaction occurred on February 26, 2026.
• The RSUs were granted at a price of $0.00 per share.
• Following this transaction, the director's total beneficial ownership increased to 243,777 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation, which does not signal a change in company fundamentals.

Positives

• Increased equity alignment between the director and shareholders.
• The grant indicates continued commitment from a key board member.

Negatives

• The issuance of new equity results in potential dilution for existing shareholders.

Risks

• Vesting is contingent upon the director remaining employed by the issuer through the specified dates.

Future Outlook

The RSUs vest in two equal tranches: 50% on the date of grant (February 26, 2026) and 50% on the six-month anniversary of the grant date, subject to continued service.

Industry Context

StockSavvy.ai notes that equity-based compensation for directors is standard practice in the biotechnology sector to align board incentives with long-term corporate performance.

Comparison to Industry Standards

• The use of RSU grants for board members is consistent with standard corporate governance practices for small-cap biotech firms.
• The vesting schedule is relatively short, which is common for director compensation in high-volatility sectors.

Stakeholder Impact

• Shareholders may experience minor dilution due to the issuance of 200,000 new shares.

Next Steps

• Vesting of the remaining 50% of the RSU award on August 26, 2026.

Key Dates

Keywords

BrainStorm Cell Therapeutics, BCLI, Form 4, Insider Trading, Restricted Stock Units, Equity Compensation